Form F-X - Appointment of Agent for Service of Process and Undertaking:
SEC Accession No. 0001104659-20-070932
Filing Date
2020-06-08
Accepted
2020-06-08 17:29:20
Documents
1
Effectiveness Date
2020-06-08

Document Format Files

Seq Description Document Type Size
1 F-X tm2021919d2_fx.htm F-X 18875
  Complete submission text file 0001104659-20-070932.txt   20472
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filed by) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-X
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Subject) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-X | Act: 33 | File No.: 333-239025 | Film No.: 20950118
SIC: 2834 Pharmaceutical Preparations